This information is disclosed in accordance with the Securities Markets Act, the
Financial Instruments Trading Act or demands made in the exchange rules.
* Profit before tax SEK 2,868m (1,375)
* Earnings per share before dilution SEK 14.18 (5.32)
* Proposed dividend SEK 10.50 per share (9.50)
* 2:1 share split proposed
* Mixed but satisfactory underlying development in the holdings
* Acquisition of Biolin Scientific, HL Display, KVD Kvarndammen and Stofa
* Major add-ons in EuroMaint (RSM Group) and AH Industries (RM Group)
* Exit Haglöfs and 11% of Lindab - total exit gain SEK 1,320m
* Agreement on sale of Superfos
* Camfil sold after end of the period - exit gain SEK 586m
* Total return on Ratos shares +40%
Telephone conference at 10.00 a.m. CET, tel +46 8 505 201 10
Stockholm, 17 February 2011
Arne Karlsson
CEO
For further information, please contact:
Arne Karlsson, CEO, +46 8 700 17 00
Emma Rheborg, Head of Corporate Communications and IR, +46 8 700 17 20
Financial calendar from Ratos:
Annual General Meeting 2011 5 April 2011
Interim Report January - March 2011 5 May 2011
Interim Report January - June 2011 19 August 2011
Interim Report January - September 2011 9 November 2011
Ratos is a private equity conglomerate. The company's mission is to maximise
shareholder value over time through the professional, active and responsible
exercise of its ownership role in primarily medium to large unlisted Nordic
companies. Ratos's holdings include AH Industries, Anticimex, Arcus-Gruppen,
Biolin Scientific, Bisnode, Contex, DIAB, EuroMaint, GS-Hydro, Hafa Bathroom
Group, HL Display, Inwido, Jøtul, KVD Kvarndammen, Lindab, Medisize, Mobile
Climate Control, SB Seating, Stofa, Superfos and Other holdings. Ratos is listed
on NASDAQ OMX Stockholm and market capitalisation amounts to approximately SEK
38 billion.
The full report including tables can be downloaded from the following link:
